Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers.
Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers.
复制标题
DOI:
10.1002/acn3.559
复制
发表时间:
2018-05
影响因子:
5.3
通讯作者:
Lee SE
中科院分区:
文献类型:
--
作者:
Meeter LHH;Gendron TF;Sias AC;Jiskoot LC;Russo SP;Donker Kaat L;Papma JM;Panman JL;van der Ende EL;Dopper EG;Franzen S;Graff C;Boxer AL;Rosen HJ;Sanchez-Valle R;Galimberti D;Pijnenburg YAL;Benussi L;Ghidoni R;Borroni B;Laforce R Jr;Del Campo M;Teunissen CE;van Minkelen R;Rojas JC;Coppola G;Geschwind DH;Rademakers R;Karydas AM;Öijerstedt L;Scarpini E;Binetti G;Padovani A;Cash DM;Dick KM;Bocchetta M;Miller BL;Rohrer JD;Petrucelli L;van Swieten JC;Lee SE
To evaluate poly(GP), a dipeptide repeat protein, and neurofilament light chain (NfL) as biomarkers in presymptomatic C9orf72 repeat expansion carriers and patients with C9orf72‐associated frontotemporal dementia. Additionally, to investigate the relationship of poly(GP) with indicators of neurodegeneration as measured by NfL and grey matter volume. We measured poly(GP) and NfL levels in cerebrospinal fluid (CSF) from 25 presymptomatic C9orf72 expansion carriers, 64 symptomatic expansion carriers with dementia, and 12 noncarriers. We explored associations with grey matter volumes using region of interest and voxel‐wise analyses. Poly(GP) was present in C9orf72 expansion carriers and absent in noncarriers (specificity 100%, sensitivity 97%). Presymptomatic carriers had lower poly(GP) levels than symptomatic carriers. NfL levels were higher in symptomatic carriers than in presymptomatic carriers and healthy noncarriers. NfL was highest in patients with concomitant motor neuron disease, and correlated with disease severity and survival. Associations between poly(GP) levels and small grey matter regions emerged but did not survive multiple comparison correction, while higher NfL levels were associated with atrophy in frontotemporoparietal cortices and the thalamus. This study of C9orf72 expansion carriers reveals that: (1) poly(GP) levels discriminate presymptomatic and symptomatic expansion carriers from noncarriers, but are not associated with indicators of neurodegeneration; and (2) NfL levels are associated with grey matter atrophy, disease severity, and shorter survival. Together, poly(GP) and NfL show promise as complementary biomarkers for clinical trials for C9orf72‐associated frontotemporal dementia, with poly(GP) as a potential marker for target engagement and NfL as a marker of disease activity and progression.
登录
查看更多内容
影响因子:
16.2
作者:
Ash PE;Bieniek KF;Gendron TF;Caulfield T;Lin WL;Dejesus-Hernandez M;van Blitterswijk MM;Jansen-West K;Paul JW 3rd;Rademakers R;Boylan KB;Dickson DW;Petrucelli L
通讯作者:
Petrucelli L
影响因子:
9.9
作者:
Lu CH;Macdonald-Wallis C;Gray E;Pearce N;Petzold A;Norgren N;Giovannoni G;Fratta P;Sidle K;Fish M;Orrell R;Howard R;Talbot K;Greensmith L;Kuhle J;Turner MR;Malaspina A
通讯作者:
Malaspina A
影响因子:
5.7
作者:
Diedrichsen, Joern;Balsters, Joshua H.;Ramnani, Narender
通讯作者:
Ramnani, Narender
DOI:
10.1016/j.nicl.2016.12.006
发表时间:
2017
期刊:
NeuroImage. Clinical
影响因子:
--
作者:
Lee SE;Sias AC;Mandelli ML;Brown JA;Brown AB;Khazenzon AM;Vidovszky AA;Zanto TP;Karydas AM;Pribadi M;Dokuru D;Coppola G;Geschwind DH;Rademakers R;Gorno-Tempini ML;Rosen HJ;Miller BL;Seeley WW
通讯作者:
Seeley WW
DOI:
10.1016/j.dadm.2015.11.001
发表时间:
2015-12-01
期刊:
Alzheimer's & dementia (Amsterdam, Netherlands)
影响因子:
--
作者:
Pijnenburg, Yolande A L;Verwey, Nicolaas A;Teunissen, Charlotte E
通讯作者:
Teunissen, Charlotte E